Paul A. Dickinson

4.1k citations
42 papers · 3.1k indexed · 1 hit paper · h-index 21
Topics
Lung Cancer Treatments and Mutations (11 papers)Drug Solubulity and Delivery Systems (9 papers)Pharmacogenetics and Drug Metabolism (7 papers)

In The Last Decade

Paul A. Dickinson

42 papers receiving 3.0k citations

Hit Papers

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung C...2015202620182022201550010001.5k

Peers

Paul A. Dickinson
Comparison fields: 5 of 118
  • Pulmonary and Respiratory Medicine 1.7k
  • Oncology 1.5k
  • Molecular Biology 977
  • Pharmaceutical Science 653
  • Cancer Research 426
Replace Ana Ruiz-Garcı́a with:
Ana Ruiz-Garcı́a United States
E. Brendel Germany
Nahoko Kaniwa Japan
Paul Statkevich United States
Stijn L.W. Koolen Netherlands
Bruno Reigner Switzerland
Jürgen Venitz United States
Laurent Salphati United States
Masashi Kanai Japan
Laurent P. Rivory Australia
Paul A. Dickinson relative to Ana Ruiz-Garcı́a United States Ana Ruiz-Garcı́a's profile →
Citations per field
00.5×3.7×
Ana Ruiz-Garcı́a · 1×
Citations per year

Countries citing papers authored by Paul A. Dickinson

Since Specialization
Citations

This map shows the geographic impact of Paul A. Dickinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Dickinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Dickinson more than expected).

Fields of papers citing papers by Paul A. Dickinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Dickinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Dickinson. The network helps show where Paul A. Dickinson may publish in the future.

Co-authorship network of co-authors of Paul A. Dickinson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Dickinson. A scholar is included among the top collaborators of Paul A. Dickinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Dickinson. Paul A. Dickinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 6
3 3
4 105
5 115
6
AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancerbreakdown →
1585
7 299
8 85
9 88
10 51
11 23
12 15
13 23
14 87
15 87
16 17
17 39
18 3
19 23
20 2

About Paul A. Dickinson

Paul A. Dickinson is a scholar working on Pharmaceutical Science, Pharmacology and Oncology, having authored 42 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Drug Solubulity and Delivery Systems (9 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Pharmaceutical Science (653 citations), Oncology (1.5k citations) and Pulmonary and Respiratory Medicine (1.7k citations). Paul A. Dickinson has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Mireille Cantarini, Paul Frewer, Enriqueta Felip, David Planchard, Pasi A. Jänne, Malcolm Ranson, Kathryn H. Brown, Yuichiro Ohe, James Chih‐Hsin Yang and Suresh S. Ramalingam. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026